These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31435916)

  • 1. Intrathecal Drug Delivery.
    De Andrés J; Rubio-Haro R; De Andres-Serrano C; Asensio-Samper JM; Fabregat-Cid G
    Methods Mol Biol; 2020; 2059():75-108. PubMed ID: 31435916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal delivery of analgesics.
    De Andres J; Asensio-Samper JM; Fabregat-Cid G
    Methods Mol Biol; 2014; 1141():249-78. PubMed ID: 24567144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in intrathecal drug delivery.
    Lawson EF; Wallace MS
    Curr Opin Anaesthesiol; 2012 Oct; 25(5):572-6. PubMed ID: 22825049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term Outcomes Using Intrathecal Drug Delivery Systems in Complex Regional Pain Syndrome.
    Herring EZ; Frizon LA; Hogue O; Mejia JU; Rosenquist R; Bolash RB; Machado AG; Nagel SJ
    Pain Med; 2019 Mar; 20(3):515-520. PubMed ID: 29889241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal pain pumps: indications, patient selection, techniques, and outcomes.
    Bolash R; Mekhail N
    Neurosurg Clin N Am; 2014 Oct; 25(4):735-42. PubMed ID: 25240660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal ziconotide and baclofen provide pain relief in seven patients with neuropathic pain and spasticity: case reports.
    Saulino M; Burton AW; Danyo DA; Frost S; Glanzer J; Solanki DR
    Eur J Phys Rehabil Med; 2009 Mar; 45(1):61-7. PubMed ID: 19156022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal Drug Delivery Systems for Refractory Pancreatic Cancer Pain: Observational Follow-up Study Over an 11-Year Period in a Comprehensive Cancer Center.
    Carvajal G; Dupoiron D; Seegers V; Lebrec N; Boré F; Dubois PY; Leblanc D; Delorme T; Jubier-Hamon S
    Anesth Analg; 2018 Jun; 126(6):2038-2046. PubMed ID: 29543644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecal Pain Therapy for the Management of Chronic Noncancer Pain.
    Sukul VV
    Neurosurg Clin N Am; 2019 Apr; 30(2):195-201. PubMed ID: 30898270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Title: Quantifying the change of spasticity after intrathecal baclofen administration: A descriptive retrospective analysis.
    Pittelkow TP; Bendel MA; Lueders DR; Beck LA; Pingree MJ; Hoelzer BC
    Clin Neurol Neurosurg; 2018 Aug; 171():163-167. PubMed ID: 29913361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal Drug Delivery Systems for Cancer Pain: An Analysis of a Prospective, Multicenter Product Surveillance Registry.
    Stearns LM; Abd-Elsayed A; Perruchoud C; Spencer R; Hammond K; Stromberg K; Weaver T
    Anesth Analg; 2020 Feb; 130(2):289-297. PubMed ID: 31567325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined intrathecal baclofen and morphine infusion for the treatment of spasticity related pain and central deafferentiation pain.
    Gatscher S; Becker R; Uhle E; Bertalanffy H
    Acta Neurochir Suppl; 2002; 79():75-6. PubMed ID: 11974992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal therapy for pain in cancer patients.
    Dupoiron D
    Curr Opin Support Palliat Care; 2019 Jun; 13(2):75-80. PubMed ID: 30896454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal Drug Delivery and Spinal Cord Stimulation for the Treatment of Cancer Pain.
    Xing F; Yong RJ; Kaye AD; Urman RD
    Curr Pain Headache Rep; 2018 Feb; 22(2):11. PubMed ID: 29404792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Intrathecal Pumps in Nonmalignant Pain.
    Ginalis EE; Ali S; Mammis A
    Neurosurg Clin N Am; 2022 Jul; 33(3):305-309. PubMed ID: 35718400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional benefits and cost/benefit analysis of continuous intrathecal baclofen infusion for the management of severe spasticity.
    Sampson FC; Hayward A; Evans G; Morton R; Collett B
    J Neurosurg; 2002 Jun; 96(6):1052-7. PubMed ID: 12066906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of severe spasticity treatment with intrathecal Baclofen in multiple sclerosis patients: Long term follow-up.
    Stampacchia G; Gerini A; Mazzoleni S
    NeuroRehabilitation; 2016 Apr; 38(4):385-93. PubMed ID: 27061166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ziconotide for the treatment of severe spasticity after spinal cord injury.
    Ridgeway B; Wallace M; Gerayli A
    Pain; 2000 Mar; 85(1-2):287-9. PubMed ID: 10692630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous intrathecal baclofen administration by a fully implantable electronic pump for severe spasticity treatment: our experience.
    Guglielmino A; Sorbello M; Fazzio S; Zingale SF; Bucolo GE; Pittalà G; Castiglione A; Patti F; Mangiameli S
    Minerva Anestesiol; 2006 Oct; 72(10):807-20. PubMed ID: 17006418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale and Recent Advances in Targeted Drug Delivery for Cancer Pain: Is It Time to Change the Paradigm?
    Dupoiron D; Duarte R; Carvajal G; Aubrun F; Eldabe S
    Pain Physician; 2022 May; 25(3):E414-E425. PubMed ID: 35652767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathecal Drug Delivery Systems for Noncancer Pain: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2016; 16(2):1-77. PubMed ID: 27026797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.